Actively Recruiting

Phase Not Applicable
Age: 18Years +
FEMALE
NCT06459271

Feasibility of CALM in Patients With Ovarian Cancer

Led by University Health Network, Toronto · Updated on 2025-12-16

50

Participants Needed

1

Research Sites

113 weeks

Total Duration

On this page

Sponsors

U

University Health Network, Toronto

Lead Sponsor

C

Canadian Institutes of Health Research (CIHR)

Collaborating Sponsor

AI-Summary

What this Trial Is About

The goal of this feasibility trial is to determine the feasibility and acceptability of implementing a brief evidence-based psychotherapeutic intervention, Managing Cancer And Living Meaningfully (CALM), at the time of a new diagnosis and recurrence of ovarian cancer (OC). The main questions are: 1. Is it feasible and acceptable to implement CALM for patients with newly diagnosed or recently recurred advanced OC 2. What are the prevalence and correlates of traumatic stress symptoms at baseline in patients with newly diagnosed or recently recurred advanced OC Participants will be asked to complete questionnaires at baseline and at 3 and 6 months following a diagnosis or recurrence of stage III or IV OC. Participants will also be invited to participate in 3-6 sessions of CALM therapy.

CONDITIONS

Official Title

Feasibility of CALM in Patients With Ovarian Cancer

Who Can Participate

Age: 18Years +
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • New diagnosis or recurrence of stage III or stage IV ovarian cancer
  • Age 18 years or older
  • Able to complete outcome measures and participate in CALM therapy in English
Not Eligible

You will not qualify if you...

  • Cognitive impairment noted in medical records, communicated by the clinic team, or identified by research staff
  • Currently receiving psychological or psychiatric counseling from the Department of Supportive Care at Princess Margaret Cancer Centre

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Princess Margaret Cancer Centre

Toronto, Ontario, Canada, M5G 2M9

Actively Recruiting

Loading map...

Research Team

M

Megan A George, BSc

CONTACT

A

Anne Rydall, MSc

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here